复方倍他米松注射液联合超短波治疗耳廓假性囊肿临床疗效观察.docVIP

复方倍他米松注射液联合超短波治疗耳廓假性囊肿临床疗效观察 　　【摘要】目的观察复方倍他米松注射液联合超短波治疗耳廓假性囊肿的临床疗效。方法将113例耳廓假性囊肿患者随机分为治疗组(57例)与对照组(56例), 对照组采用抽液后囊内局部注射复方倍他米松注射液进行治疗, 治疗组采用抽液后囊内注射复方倍他米松注射液联合超短波理疗2周, 并对两组患者临床疗效进行对比。结果治疗结束后, 治疗组临床总有效率为96.49%, 显著优于对照组的82.14%(P0.05)。结论复方倍他米松注射液联合超短波治疗耳廓假性囊肿的临床疗效确切, 值得推广应用。 　　【关键词】复方倍他米松注射液；超短波；耳廓假性囊肿 　　 　　Effect of compound betamethasone injection combined with ultrashort wave in the treatment of auricular pseudocy CAO Xiong-wei. Health Center of Haiyan Town, Taishan 529234, China 　　【Abstract】ObjectiveTo observe the clinical efficacy of compound betamethasone injection combined with ultrashort wave in treating pseudocyst of auricle. MethodsFrom January 2008 to January 2013, 113 cases with pseudocyst of auricle were randomly divided into treatment group (57 cases) and control group (56 cases), the cases in the control group were treated by intracapsular injection of compound betamethasone injection, the cases in the treatment group were treated with compound betamethasone injection combined with ultrashort wave therapy for 2 weeks, and the clinical effects of two groups were compared. ResultsThe total clinical effective rate of the treatment group was 96.49%, which is significantly better than 82.14% of the control group (P0.05). ConclusionCompound betamethasone injection combined with ultrashort wave can obtain satisfactory clinical effects in treating pseudocyst of auricle, it is worthy of clinical application. 　　【Key words】Compound betamethasone injection; Ultrashort wave; Pseudocyst of auricle耳廓假性囊肿是耳鼻咽喉科常见疾病, 是一种耳软骨层间的无菌性渗出性炎症反应［1］。患者耳廓外侧面局限性肿胀、形成囊肿样隆起, 内含浆液性渗出物。该病多发于青年男性, 多发生于一侧耳廓, 临床多通过穿刺抽液、导管插入引流、冷冻、注射药物等手段对其进行治疗, 但治疗效果不甚理想, 复发率较高［2］。作者所在医院采用复方倍他米松注射液联合超短波对57例耳廓假性囊肿患者进行治疗, 经临床观察, 取得了满意的治疗效果, 现报告如下。 　　1资料与方法 　　1. 1一般资料全部病例均为本院2008年1月~2013年1月收治的耳廓假性囊肿患者, 共113例, 均为单耳发病, 按就诊先后顺序随机分为治疗组(57例)和对照组(56例)。患病无明显诱因, 耳廓局部增厚、肿胀、积液, 病变范围局限, 表面肤色正常。其中治疗组中男52例, 女5例；年龄32~58岁, 平均年龄(48.6±4.9)岁；发病时程1~29个月, 平均病程(6.92±7.3)个月；囊肿直径1.3~4.1 cm, 平均直径(2.9±0.3)cm；囊肿位于舟状窝27例, 三角窝24例,